GL1X · GenesisL1 explorer

Research workbench

HIV protease (pr) with tl-3 in active site and 4-methylbenzene-1,2- diamine in exosite

Analyse HIV protease (pr) with tl-3 in active site and 4-methylbenzene-1,2- diamine in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VEA
Type
protein
Length
99 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
EC
3.4.23.16
UniProt
Q72863
Ligands
3TL, 9AY
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 protease (EC 3.4.23.16)protein994% helix, 49% strandQ72863

Ligands and binding sites

  • 3TL · benzyl [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-dibenzyl-8,9-dihydroxy-1,16-dimethyl-4,13-bis(1-methylethyl)-2,5,12,15,18-pentaoxo-20-phenyl-19-oxa-3,6,11,14,17-pentaazaicos-1-yl]carbamate · ligand · chains A
  • 9AY · 4-methylbenzene-1,2-diamine · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.480.7822empty
2660.300.7416empty

Compared structures

  • 5VEA · HIV Protease (PR) with TL-3 in active site and 4-methylbenzene-1,2-diamine in exosite · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.